Belpointe Asset Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1721242
RENO, NV
Position in REGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,709,852
-$25,311 QoQ
Shares Held
2,213
-1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Belpointe Asset Management LLC holds $7,054,376 across 13 Biotechnology names. REGN ranks #2 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
34,042 | $1,729,333 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,213 | $1,709,852 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,776 | $1,239,595 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
15,088 | $975,137 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
38,445 | $308,713 | |
| 6 | GALT |
Galectin Therapeutics Inc
|
106,139 | $296,127 | |
| 7 | INCY |
Incyte Corp
|
2,742 | $258,077 | |
| 8 | KLRS |
Kalaris Therapeutics, Inc.
|
40,000 | $230,800 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,709,852 | 2,213 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,735,163 | 2,248 | Shares | Sole | 2026-01-27 | |
| 2025-03-31 | $641,206 | 1,011 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $1,403,290 | 1,970 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,937,435 | 1,843 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,880,292 | 1,789 | Shares | Other | 2024-08-02 | |
| 2024-03-31 | $1,264,711 | 1,314 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $288,957 | 329 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $668,243 | 812 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $268,015 | 373 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $856,180 | 1,042 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $795,803 | 1,103 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $863,154 | 1,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $383,643 | 649 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $456,068 | 653 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,120,948 | 1,775 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,207,454 | 5,300 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,372,891 | 2,458 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,129,603 | 4,501 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $203,389 | 421 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $234,547 | 419 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $650,466 | 1,043 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $516,610 | 1,058 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||